Is a
Patent attributes
Current Assignee
0
Patent Jurisdiction
Patent Number
Patent Inventor Names
Nathanael Schiander Gray0
Patricia Imbach0
Pascal Furet0
Yi Liu0
Ruo Steensma0
Greg Chopiuk0
Joseph Schoepfer0
Date of Patent
March 13, 2007
0Patent Application Number
109564120
Date Filed
September 30, 2004
0Patent Primary Examiner
Patent abstract
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, BCR-Abl, EGF-R, c-erbB2 kinase (HER-2), CHK2, FGFR3, p70S6K, PKC, PDGF-R, p38, TGFβ, KDR, c-Kit, b-RAF, c-RAF, FLT1 and/or FLT4 kinases.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.